A Randomized Controlled Trial Testing the Efficacy of an Insulin-Dose Learning Algorithm in Adults with Type 1 Diabetes

一项测试胰岛素剂量学习算法对成人 1 型糖尿病患者疗效的随机对照试验

• 批准号: 428886
• 负责人: Kobayati Alessandra
• 金额: $ 1.27万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-12-01 至 2020-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428886&lang=en
• 关键词: Clinical Research; Enhanced Treatment Technology For Type 1 Diabetes; Glucose Control; Glucose Sensor Technology; Insulin Intensive Therapy; Multiple Daily Injections; Personalized Learning Algorithm; Randomized Controlled Trial; Smart Insulin Pens; Type

"Type 1 diabetes (T1D) is a metabolic disease that results in no insulin production from the pancreas, a hormone required to allow glucose to be used as energy. Despite advances in diabetic treatment technology, maintaining glucose targets is difficult to

1型糖尿病(T1D)是一种代谢性疾病，导致胰腺不能产生胰岛素，胰岛素是一种允许葡萄糖用作能量所需的激素。尽管糖尿病治疗技术取得了进步，但维持血糖目标是困难的